Escitalopram (Lexapro)
Escitalopram (Lexapro) is an antidepressant medication that can be effective for treating depression and anxiety disorders, making it a key option in managing these common mental health conditions.
Studies have found that escitalopram is generally effective for treating major depressive disorder, though its benefits compared to other antidepressants are modest. It has also been shown to help with anxiety when mindfulness-based stress reduction techniques are not sufficient on their own. The medication works by increasing levels of serotonin in the brain, which can improve mood and reduce symptoms of depression and anxiety.
Escitalopram is often connected to discussions about selective serotonin reuptake inhibitors (SSRIs) as a whole, given its mechanism of action. It also frequently comes up alongside other antidepressants used for similar conditions, like fluoxetine or sertraline.
While escitalopram can be effective, the evidence base includes older studies and may not fully capture current treatment outcomes or long-term effects.
Sources
- Mindfulness-Based Stress Reduction vs Escitalopram for the Treatment of Adults With Anxiety Disorders: A Randomized Clinical Trial. (PMID:36350591)
- Escitalopram (Lexapro) for depression. (PMID:14677669)
- Citalopram | Escitalopram (Celexa® | Lexapro®). (PMID:35951902)
- Escitalopram versus other antidepressive agents for major depressive disorder: a systematic review and meta-analysis. (PMID:38001423)
- The clinical pharmacokinetics of escitalopram. (PMID:17375980)
- Escitalopram. (PMID:12387707)
_Worker-drafted node, Hermes writer enrichment, pending editorial review._
Connections
No connections recorded yet.
Sources
- Mindfulness-Based Stress Reduction vs Escitalopram for the Treatment of Adults With Anxiety Disorders: A Randomized Clinical Trial. (2023) pubmed
- Escitalopram (Lexapro) for depression. (2003) pubmed
- Citalopram | Escitalopram (Celexa® | Lexapro®). (1994) pubmed
- Escitalopram versus other antidepressive agents for major depressive disorder: a systematic review and meta-analysis. (2023) pubmed
- The clinical pharmacokinetics of escitalopram. (2007) pubmed
- Escitalopram. (2002) pubmed
- The safety and efficacy of escitalopram and sertraline in post-stroke depression: a randomized controlled trial. (2024) pubmed
- Escitalopram for agitation in Alzheimer's dementia: a randomized controlled phase 3 trial. (2025) pubmed
- A Multicenter Double-Blind, Placebo-Controlled Trial of Escitalopram in Children and Adolescents with Generalized Anxiety Disorder. (2023) pubmed
- Escitalopram-associated rhabdomyolysis. (2023) pubmed